Clover Biopharmaceuticals-B (02197.HK) 0.000 (0.000%) announced its annual results for the year ended last December. The revenue was RMB3.505 million, representing a year-on-year decrease of 90.9%. The loss narrowed to RMB205 million, compared to a loss of RMB903 million in the same period last year; the loss per share was RMB0.16. No dividend was declared.
AASTOCKS Financial News